- Serum concentrations fibroblast growth factor 19 21 in patients with restrictive type anorexia nervosaPublication without faculty affiliation
- Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge2017 | First Faculty of Medicine
- Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa +12009 | First Faculty of Medicine
- Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa2008 | Publication without faculty affiliation
- Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill Patients2019 | First Faculty of Medicine
- Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-alpha agonist treatment2011 | First Faculty of Medicine
- Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus2016 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Chyme Reinfusion Restores the Regulatory Bile Salt-FGF19 Axis in Patients With Intestinal Failure2021 | First Faculty of Medicine
- Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome2010 | First Faculty of Medicine
- Novel metabolic regulators and inflammatory cytokines in the etiopathogenesis of type 2 diabetes mellitus and obesity: the influence of pharmacological and dietary interventionsPublication without faculty affiliation
- Bile Acid Malabsorption in Inflammatory Bowel Disease: Assessment by Serum Markers2011 | First Faculty of Medicine
- Bile Acid Malabsorption in Inflammatory Bowel Disease: Assessment by Serum Markers2011 | Second Faculty of Medicine
- Low circulating concentrations of citrulline and FGF19 predict chronic cholestasis and poor survival in adult patients with chronic intestinal failure: development of a Model for End-Stage Intestinal Failure (MESIF risk score)2019 | First Faculty of Medicine